Tianjin Tianyao Pharmaceuticals Co., Ltd. Class ASSE: 600488

"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Provision for Impairment and Write-off of Assets for the First Half of 2026

Aug 26, 2026 · Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Provision for Impairment and Write-off of Assets for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A

"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining the Drug Registration Certificate by the Subsidiary from the Ministry of Health (Myanmar) for Pediatric Compound Amino Acid Injection (18AA-I)Aug 18
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Addition of a New Specification of a Subsidiary's Drug and Passing of the Generic Drug Consistency EvaluationAug 15
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on the Proposed Selection of Subsidiary's Products in the National Centralized Drug ProcurementAug 5
"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining Drug Registration Certificate by SubsidiaryAug 4

All Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A news releases